Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage

Nienke Visser,Laure C. M. Herreman,Jennifer Vandooren,Rafaela Vaz Sousa Pereira,Ghislain Opdenakker,Robin E. J. Spelbrink,Maarten H. Wilbrink,Edwin Bremer,Reinoud Gosens,Martijn C. Nawijn,Heidi H. van der Ende-Metselaar,Jolanda M. Smit,Marc C. Laus,Jon D. Laman
DOI: https://doi.org/10.1007/s00109-024-02423-x
2024-02-22
Journal of Molecular Medicine
Abstract:Viruses critically rely on various proteases to ensure host cell entry and replication. In response to viral infection, the host will induce acute tissue inflammation pulled by granulocytes. Upon hyperactivation, neutrophil granulocytes may cause undue tissue damage through proteolytic degradation of the extracellular matrix. Here, we assess the potential of protease inhibitors (PI) derived from potatoes in inhibiting viral infection and reducing tissue damage. The original full spectrum of potato PI was developed into five fractions by means of chromatography and hydrolysis. Individual fractions showed varying inhibitory efficacy towards a panel of proteases including trypsin, chymotrypsin, ACE2, elastase, and cathepsins B and L. The fractions did not interfere with SARS-CoV-2 infection of Vero E6 cells in vitro. Importantly, two of the fractions fully inhibited elastin-degrading activity of complete primary human neutrophil degranulate. These data warrant further development of potato PI fractions for biomedical purposes, including tissue damage crucial to SARS-CoV-2 pathogenesis.
genetics & heredity,medicine, research & experimental
What problem does this paper attempt to address?
The main problem this paper attempts to address is exploring whether protease inhibitors (PIs) extracted from potatoes can inhibit the viral replication cycle and reduce tissue damage mediated by leukocyte enzymes, particularly in inflammatory diseases. Specifically, the study aims to evaluate the effects of different fractions of potato protease inhibitors in the following two aspects: 1. **Inhibition of SARS-CoV-2 infection and replication**: The researchers hypothesize that since the viral replication cycle depends on both host and viral proteases, potato protease inhibitors can inhibit SARS-CoV-2 infection and replication. 2. **Inhibition of leukocyte enzyme activity**: The researchers also hypothesize that these protease inhibitors can inhibit proteases released by leukocytes (especially granulocytes and macrophages), thereby reducing tissue damage caused by inflammation. Through these studies, the authors hope to provide a basis for the development of new biomedical applications, particularly targeting tissue damage in viral infections and excessive inflammatory responses (such as COVID-19).